Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
58.6M
-
Number of holders
-
211
-
Total 13F shares, excl. options
-
61.7M
-
Shares change
-
+1.76M
-
Total reported value, excl. options
-
$2.05B
-
Value change
-
+$65.2M
-
Put/Call ratio
-
0.78
-
Number of buys
-
107
-
Number of sells
-
-100
-
Price
-
$33.26
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) as of Q2 2025
247 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q2 2025.
AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) has 211 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61.7M shares
.
Largest 10 shareholders include FARALLON CAPITAL MANAGEMENT LLC (5.77M shares), VANGUARD GROUP INC (5.68M shares), BlackRock, Inc. (4.83M shares), Bellevue Group AG (3.59M shares), Erste Asset Management GmbH (2.33M shares), Commodore Capital LP (2.33M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.27M shares), STATE STREET CORP (1.95M shares), MACQUARIE GROUP LTD (1.9M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.41M shares).
This table shows the top 211 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.